Comparison of traditional and novel hemophilia therapies. Similarities and differences of hemophilia A treatment between FVIII replacement therapy, emicizumab, fitusiran, and anti-TFPI antibodies with regard to patient target group, mode of administration, and therapeutic levels over time.